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INTRODUCTION
Until  a  few years  ago,  it  was  generally  believed  that  breast  tumor  should  be  excised  and 
histologically  examined to  determine  its  nature  with  certainty –  because  the  preoperative  physical 
assessment alone was associated with too much uncertainty.
Eventually,  with  the  advent  of  mammography,  a  radiological  tool  became available  to  the 
surgeons  to  make  a  pre-operative  diagnosis  of  the  breast  with  a  reasonable  degree  of  accuracy. 
However,  it  was  the  introduction  of  FNAC  that  changed  the  entire  outlook  to  the  matter.  The 
combination of Physical examination, Mammography and FNAC came to be called upon as the “Triple 
Test” for assessment of breast lumps and has now become the gold standard in the work-up of the 
same.
Breast Ultrasound has now become available at higher resolutions, and is proving to be a highly 
useful adjunct to mammography. The wide acceptance of ultrasound as a diagnostic modality has been 
documented extensively in literature. However, opinions vary about the usefulness of USG breast in the 
evaluation  of  masses,  and,  surgeons  are  cautioned  to  be  aware  of  its  attributes  as  well  as  its 
deficiencies.
The ‘Modified Triple Test’ utilizes-Physical Examination, Ultrasonography of the breast as the 
radiological method, and FNAC for the diagnosis of palpable breast lumps; and it is gaining acceptance 
with the recent advances in technology and refinements in the interpretative criteria of sonographically 
characterized masses.
Today, the studies concentrate on whether a benign result of the tests mentioned above makes 
excision biopsy unnecessary. Most often, this question arises in connection with localized changes in 
breasts with Fibrocystic diseases. For these tests to be adopted they must however,  have the same 
degree of accuracy as excisional biopsy – because, non-excision of a malignant tumor is unacceptable.
REVIEW OF LITERATURE
Medical literature abounds with studies of evaluation of breast lumps that emphasizes that the 
statement “every palpable mass must be assessed and clarified”.
Hermansen C. et.al4 in 1987 prospectively studied 650  breast tumors and applied the term 
‘Triple test’ to the traid of physical examination; mammography and FNAC used to diagnose them. He 
concluded  that  the  diagnostic  accuracy  of  the  triple  test  is  comparable  to  that  of  histological 
examination.  Hardy JR.  et.  Al6.  assessed  143 patients  with  palpable  breast  modules  with  clinical 
examination;  FNAC mammography;  ultrasonography and  magnetic  resonance  imaging  (MRI)  and 
concluded  that  the  combination  of  cytology  and  ultrasound  was  best  at  correctly  diagnosing 
malignancy.
Lawrence  N Bassett  et.  Al.7  assessed  the  usefulness  of  mammography and  sonography in 
women  less  than  35years  of  age  (1016  women)  during  a  8  year  period.  This  study  found  that 
mammography was  not  useful  in  women  less  than  35  years.  However  sonography was  useful  in 
avoiding unnecessary biopsies and for this reason was the intial examination in younger women. But it 
was not useful in detecting nonpalpable carcinomas or in differentiating benign from malignant solid 
masses.
Vetto  JJ  et  al  in  1996  studied  55  women  below  the  recommended  age  of  screening 
mammography with the 3 elements of ‘Modified Triple Test’
(C/E,  Usg;  FNAC/CNB).  The  test  had  a  specificity  and  negative  predictive  value  of  100%  for 
malignancy.  They concluded that  use  of  MTT for  diagnosis  of  palpable  breast  lesions  in  younger 
women yields high diagnostic accuracy without the need for routine open biopsy, resulting in overall 
reduction patient charges.
Purasri P et. al3. retrospectively assessed 603 patients with breast lumps using the ‘Quadruple 
test’ – C/E/USG/Mammography/FNAC. A stepwise logistic discriminant analysis was used to derive a 
novel diagnostic index. This predicted the diagnosis in 98% of women <35 years correctly.
Hatada  T  et.  al5.  retrospectively  studied  114  lesions  and  compared  diagnoses  obtained  by 
standard FNAC and that of ultrasound guided FNAC with surgical findings and found the accuracy to 
be  65% and 86% respectively.  They concluded that  Usg-guided FNAC improves  the  preoperative 
diagnosis especially in patients with tumor less than 2 cm.
Heiken TT et  al  conducted a prospective analysis  of office-bases breast  ultrasound, on 660 
breast  lesions  and found that  suspicious  lesions  determined  by USG had a  75% chance  of  being 
malignant; however 5% of lesions characteristic of fibroadenoma turned out to be malignancies.
Jill  S Montrey8 attempted to determine the usefulness of ultrasound as a screening tool for 
breast cancer in women <35 years, with indeterminate mammography, persistent symptoms and high 
risk history.
Literary review of Breast Usg for screening :-
Carcinoma detected
Frazier et al 1982 (3) 3/135 (2.2%)
Kopens et al 1985 (2) 3/127 (2.4%)
Basset et al 1987 (1) 1/612 (0.2%)
Frazier et al 1985 (4) 36/600 (6%)
Thus  breast  ultrasonography  when  used  correctly  can  be  effective,  but  is  not  fool  proof, 
especially in lesion <1cm.
DISCUSSION
Breast lumps are an enormous source of anxiety to patients and a stratified approach has to be 
adopted  to  properly  (chart  I)  evaluate  and  treat  them.  Though  benign  breast  diseases   are  more 
common; there is a preoccuption with malignancy (undue but understandable) amongst the patients and 
physicians alike.
The ultimate diagnosis and treatment of a patient with a dominant breast mass rests with the 
clinician. A dominant breast mass is defined as a solid or cystic lump that persists throughout the 
menstrual cycle.
The pre op assessment of a breast mass begins with a through history and systematic physical 
examination.  However  it  is  generally  accepted  that  this  alone  can  be  inadequate  for  an  accurate 
diagnosis. The breast is naturally multiondular and hence the difficulty in appreciating small nodules 
amidst the normal lumpiness is apparent. Apart from this is the varied expertise of the examiner in 
breast palpation. Thus imaging of the breast using various physical imaging modalities is important.
The earlist recorded case of breast imaging is that of SALOMON, a German pathologist who in 
1913 reported the use of the recently developed X-ray to visualize breast structure in amputated breasts. 
He demonstrated the irregular mass density and microcalcification which are still in use as the most 
important benchmarks to identify possible breast malignancy. Even today mammography remains the 
method of choice for detecting the occult, 
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Flow chart show diagnostic protocol for patients with breast complaints
nonpalpable  lesion and remains  the  standard for  imaging of  breast  against  which other  modalities 
advocated now are measured.
Other imaging modalities have now been introduced for
• Visualizing lesion missed by mammography 
• To replace mammography with another efficient, more economic device that would alsobe used 
by non-radiologists.
The  diagnostic  utility  of  ultrasonogram  was  documented  in  1950s;  but  it  was  only  with  the 
development of “grey scaling” by Korsakoff and associates in Sweden years later  that  better  issue 
representation was obtained. Recent technical advances in ultrasonography have expanded the potential 
utility of this modality in the evaluation of breast lesions far beyond distinguishing solid abnormalities 
from cystic ones.
Tissue diagnosis remains the most reliable confirmatory tool for breast lumps. In 1912, Ward 
used fine needle aspiration (FNAC) Cytology to examine lymph nodes for lymphoma. Eventually the 
procedure was attempted on patients with breast lumps in 1962 by Martin and Ellis at New York. 
Cytological interpretation requires skill particularly in view of cell types and pathologies encountered, 
but high levels of accuracy can be obtained with experience.
CLINICAL EXAMINATION
A palpable breast mass may be identified when it becomes it becomes sufficiently large to be 
differentiated from surrounding breast tissue physically by an examiner – usually the patient or the 
physician; or is perceived on an imaging examination. Determining by physical examination whether a 
mass is present can be difficult,  as, all breasts are variable in the combination of glandular tissue, 
fibrosis and fat. True masses are generally asymmetric in relation to the other breast; distinct from the 
surrounding tissue and three dimensional.
The underlying cause of complaints about the breast proves to be benign in the overwhelming 
majority  of  cases.  Breast  symptoms,  however,  induce  such  a  great  anxiety  in  the  patient  that 
malignancy needs to be excluded as speedily as possible.
The first steps in this are the classic ones of history and physical examination.
Essential points in the history include :
 Age
 Menstrual status
 Family and reproductive history
 Lactational history
 Radiation to the chest
 H/o benign breast disease
In  physical  examination  of  patients  with  a  breast  with  a  breast  complaint-seclusion,  warmth  and 
privacy  are  particularly  important  in  the  examination  of  the  breast.  This  avoids  discomfort  and 
embarrassment to the patient. Good lighting enables detection of minor abnormalities. The patient sits 
stripped to the waist. Attention is paid to 
GENERAL APPEARANCE :
Nourishment, colour, mucous membranes, palms.
Inspection from bed end :
1. Arms by side
2. Arms elevated. Looked for
Symmetry of nipples and breasts.
a. Niple abnormalities
b. Vascularity
c. Indrawing and prominence of skin
d. Tethering
e. Peau d’ orange
f. Skin nodules
g. Ulceration
Palpation :
1. Supraclavicular fossae
2. Breasts :
a. Lightly
b. Deeply  systematically  from the  areola  concentrically  outwards  including  the 
axillary tail.
3. Axillae :
1. Taking the weight of the patient’s forearm on the examiner’s.
2. Both axilae simultaneously from behind the patient.
3. Abdomen for ascites, hepatomegaly or abnormal masses.
Particularly valuable in practice are
a) inspection with arms firstly dependent, then elevated.
b) Intial  light  touch  over  the  breats  prior  to  systematic  deepar  palpation  in 
concentric circles, working outwards.
c) Simulatancous examination of the axillae performed from behind the patient.
Atypical cancer may be firm and have indistinct borders and attachments to the skin or fascia 
with dimpling or nipple retraction. Benign lesions typically have discrete borders, well defind margins 
and are mobile. Cysts can be differentiated from solid lesions by palpation.
Rosner et al reported that physical examination can correctly identify only 58% of 66 patients 
with cysts. Significant discordance among experienced examiners may occur. In one study, surgeons 
performed physical examination independently and agreed on the need for biopsy in only 73% of 15 
masses subsequently proved malignant. (Boyd et al).
Somers  et  al  studied  certain  palpable  abnormalities  defined  as  areas  of  thickening, 
predominence  of  tenderness  without  an  associated  dominant  mass  on  physical  examination;  no 
suspicious mammographic lesion; and rubbery, firm, cystic soft mass, needle sensation by FNA. The 
incidence of malignancy in these ‘suspicious’ group was less than 1% (1/06), leading to the conclusion 
that this subset of patients with palpable abnormalities did not require surgical biopsy.
Nevertheless, the physical findings or benign disease and malignancy in its earliest stages may 
overlap; and without the use of FNA and/or breast imaging, some palpable malignant lesions may be 
followed up inappropriately; leading to serious consequences for both the patient and the physician.
Although some masses exhibit distinct physical findings, an imaging evaluation is required in 
almost all  cases to characterize the palpable lesion, search for ipsilateral multifocal or multicentric 
carinoma, and screen the contralateral breast. A negative imaging evaluation, however, should never 
over rule a strongly suspiscious finding on physical examination or vice versa.
******** 
ULTRASOUND OF THE BREST
Although diagnostic ultrasound equipment has been available since the 1950s.  it  is  only in 
relatively recent years that the widespread use of this technique has been accepted by radiologists and 
then by surgeons. A lot of this has related to difficulties with earlier machines.
HISTORY
The  transducers  that  produce  the  ultrasonic  signal  were  initially  quite  crude  devices  that 
operated  with  low  frequencies.  Although  penetration  of  the  signal  is  better  at  these  frequencies, 
resolution of tissue abnormalities is not as good. It was not until the development of ‘gray scaling’ by 
Korsakoff  and associates in Sydney that better tissue representation was obtained. As the name of the 
technique implies, the images now obtained were in shapes of gray and this shading was corresponding 
to tissue changes and particularly to areas of localized pathology. Improvements in transducer design 
followed, allowing various frequencies to be used, with the higher frequencies used in areas such as the 
breast, thyroid and testis.
Even with all the advances, it must be stated and emphasized that the use of USG equipment is 
very operator dependant and interpretation of the images requires a large amount of practical training. 
Skilled interpreters of ultrasonic images, do, however, follow 3 golden rules –
1. Never make an interpretation on a single image, superimpose the ultrasonic images mentally 
to formulate a 3 dimensional image of the scanned tissues and to ensure that the displayed 
feature is consistent with the 3D image.
2. Because a feature is displayed it is not necessarily real – always rule out artifacts.
3. Because a feature is not displayed it is not necessarily not there.
The original use of USG was to determine whether a breast mass was      a cyst or solid lesion. 
Advances in technology and refinements in interpretative criteria have expanded the role of USG in 
characterizing masses as having benign, malignant or equivocal features.
BREST ULTRASOUND TECHNIQUE :
 Confirm the location of the mass noted on physical examination; a diagram from the referring 
physicians to demonstrate the lesions’ position.
 A high-resolution small parts transducer 7.5 – 10 mhz is used.
 Evaluate  the  Region  of  Interest  (ROI)  to  assess  whether  the  clinical  abnormality  is 
corresponding to the ultrasound findings.
 Patient positioning:   The patient is positioned in an oblique manner with a pillow placed under 
the shoulder of the breast to be examined.
The degree of obliquity is determined by the position of the breast – aiming to have the breast 
spread evenly over the wall, with the nipple pointing to the ceiling. The arm should be elevated 
over the patient’s  head to facilitate even distribution of the breast  tissue,  but should not be so 
elevated that the breast is retracted superiorly. A little care exercised in positioning makes the USG 
localization of the lesion less of a problem.
a. Lumps felt better in the upright position may be scanned in that position.
b. Fluid  in  cystic  masses  may  be  confirmed  by  changing  to  upright/decubits 
position.
 Region of interest is trapped with the examining finger and the transducer is placed directly 
over the abnormality.
 Examine in overlapping radial/antiradial planes – to determine relation of lesion to ducts and 
avoid errors as mistaking fat islands for solid masses.
 The entire periphery of the lesion must be evaluated in multiple planes through a 180 degree are 
to determine the nature of margins, its shape and appearance of surrounding tissue.
 Compression of tissue with the transducer is helpful in spreading apart breast tissues, flattening 
islands of fatty tissue, and eliminating artifictual shadowing.
 The rest of the breast tissue is systematically imaged from periphery to the nipple.
 The retroareolar area can be evaluated with the transducer angled into the area in multiple 
planes.
LABELING OF LESIONS :
 The lesion is labelled on a clock face.
 Its distance form nipple is given in centimeters.
 The greatest diameter should be measured.
 The height (AP diameter) is determined to obtain a height/width ratio.
NORMAL APPEARANCE OF THE BREAST :
Knowledge of normal variations of breast architecture is essential for the detection and accurate 
diagnosis of abnormalities.
SKIN :
The skin is imaged as an echogenic layer of approximately 3mm or less in thickness, often a 
hypoechnoic central line. Large areas of skin thickening are difficult to recognize without comparing 
the ROI to the opposite breast or to a normal area within the same breast. A stand-off pad may be used 
to detect subtle abnormalities.
SUBCUTANEOUS TISSUE :
The subcutaneous fat layer is a hypoechoic layer situated between the skin line and the breast 
parenchyma. Cooper’s ligaments are imaged as curvilinear lines extending from the breast tissue to the 
superficial fasical layer-producing a scalloped appearance.
Breast cancer does not arise in the subcutaneous but may involve it by direct extension.
Focal increased echotexture: Malignancy, inflammatory lesions, edema, fat necrosis, or biopsy 
scar.
Diffuse increased reflectivity : edema of any cause (e.g., Heart failure), diffuse from of breast 
cancer, inflammatory breast cancer, inflammatory mastitis, or radiation therapy.
Lesions  indigenious  to  this  plane  are  sebaceous  cysts,  epidermoid  inclusion  cysts, 
hemangiomas, and rarely smooth muscle and fibrous tissue tumors.
NIPPLE AND AREOLA :
This  is  difficult  area  to  visualize  because  of  difficulties  with  transducer  contact  by nipple 
protrusion or inversion, producing air trapping which is a source of shadowing. Compression of the 
nipple and imaging  with  multiple planes angled toward the subareolar region can be of help. Ducts 
can be visualized and traced upon the breast tissue, echogenic areas within the ducts usually represent 
debris. Visualization of a mass within a dilated duct may indicate a papilloma, carcinoma or other 
lesion.
BREAST PARENCHYMAL LAYER :
The breast tissue is more dense and uniform in the younger patient, age and parity however, are 
not good predictors for the USG appearance for any one individual.
The breast parenchyma consists of ductal, lobular and fibrous tissue in varying proportions. The 
normal appearance of the breast can range form almost completely fatty with only a few echogenic 
fibroglandular tissue with little or no fat.
Whatever the relative composition of fibroglandular tissue and fat,  the fibroglandular tissue 
should have a regular appearance of echogenic structures arranged in multiple layers parallel to the 
chest wall without distortion or swirled or pulled appearance.
Most benign and malignant lesions are imaged as nodules hypoechoic relative to paraenchyma 
and are seen most easily in homogenously echogenic breasts, which do not deform with compression. 
However,  the  most  useful  maneuver  is  imaging  in  multiple  planes,  which  will  demonstrate  the 
continuity of fat island with other areas of fat.
RETROMAMMARY AREA :
It is a hypoechoic fat plane, deep to the superficial fascia, pectoralis. Usually well demonstated 
deep to the echogenic glandular tissue.
LYMPHNODES, ARTERIES, AND VEINS
Lymphonods  are  frequently  imaged  within  the  breast  and  axilla  as  oval  nodules  with  an 
eccentric hyperechoic hilum a surrounding less echogenic rim of tissue.
Benign nodes – large in size but maintain their morphology.
Malignant  nodes  –  only  gross  abnormalities  can  be  detected.,  when  they  appear  as  lobulated 
hypoechoiec nodules.
Arteries and veins are visualized as tubular anechoic structures within  the breast. Pulsation will 
confirm the arterial nature of a vassel. Color Doppler can be used to demonstrate vascular structure 
within the breast and tumors.
******** 
CHARACTERIZATION OF BREAST MASSES
CYSTS :
The first  step  in  characterizing  breast  masses  is  cyst/solid  differentiation.  When  the  breast 
masses meet all of the diagnostic criteria for cysts the USG accuracy approaches 100%.
The criteria include :
1. Round, oval lobulated shape.
2. Anechoic
3. Well-defined posterior border
4. Increased through and through transmission
5. No alteration of surrounding parenchyma.
Unfortunately, not all cysts display these criteria. The resolution of USG for cystic lesions is up to 
5mm with 100% accuracy.
The  presence  of  internal  echoes  is  the  most  common  diagnostic  difficulty  in  cyst/solid 
differentiation. Cysts have internal echoes due to 
 Presence of cholesterol or calcium
 Hemorrhage
 Infection
FOLLOW UP OF CYSTIC LESIONS  
C  hart – (2)
SIMPLE CYST
COMPLEX CYST
Confirm benign nature and observe
Follow-up Usg at 4-6 months
No malignant or indeterminate features
Observe
Large complex/indeterminate cysts
SOLID MASSES :
Ultrasound features of a solid included –
 Primary signs – changes produced by the mass itself.
 Secondary signs – changes produced in the tissues surrounding a mass.
BENIGN CHARTERISTICS OF SOLID MASSES –  The  diagnosis  of  a  benign 
nodule based on USG findings is rarely specific. The appearance of fibro adenomas, focal fibrocystic 
changes,  tubular  adenomas  and other  benign  solid  nodules  overlap.  Characteristic  of  benign  solid 
lesions include.
1. Shape-oval, round with few lobulations
2. Margins that are sharply demarcated with a thin echogenic pseudocapsule.
3. A depth/width ratio of  <1
4. No disruption of surrounding tissues
5. Absence of malignant characteristics
Usg guided aspiration / presence intracstic 
Bloody or turboid aspirate
Usg guided biopsy / cytological evaluation
6. Homogenous low level internal echoes are usually present.
FIBROADENOMAS :
They are most common benign solid nodules. They are most commonly detected in the younger 
age group. The USG appearance is determined by the relative amounts of fibrous and epithelial tissue.
c. Enhanced through and through transmission
d. Posterior attenuation in relation to the fibrous component
e. Coarse calcifications in degenerating fibroadenomas producing shadowing.
f. Tubular structures seen with lactating and juvenile types.
g. Different from fat lobules by their non compressible characteristics.
LIPMAS AND FIBROADENOMYOLIPOMA :
1. Lobulated masses that do not distort surrounding tissues.
2. Presence of internal due to fat
FAT NECECROSIS :
1. Focal hyperechoic nodule with a central lucency.
MALIGNANT CHARTISTICS OF BREAST LESIONS
16. Stellate masses
17. Circumscribed masses
18. Diffuse edema changes
19. Calcifications
Stellate masses :  Desmoplastic reaction produces contraction of the breast tissue towards the mass, 
disrupting the normal parallel soft tissue planes.
 These masses have an irregular hypoechoic lesion with distortion of the surrounding breast tissue.
 Disruption of normal trabecular structures.
 Extension along the plane of the ducts.
 Posterior acoustic shadowing.
 Increased reflectivity of the subcutaneous tissue.
DD of stellate lesions :
 Carcinoma ( most common )
 Radial scar
 Sclerosing adenosis
 Post surgical scarring
Circumscribed masses :  Breast cancer also commonly presents as hypoechoic masses 
that appear to displace breast tissue.
 Oval, round
 Multilobulated
 Height / width ratio > 1
 >3 lobulations
 reactive halo surrounding the mass
DD of circumscribed masses :
 Carnioma – Usually the high grade NOS variety of ductal carcinoma & medullary, 
colloid, and papillary ca.,
 Metastatic lesions – from lymphona, melanoma, leukemia, sarcoma, adencarcinoma 
from other sites.
 Inflammation and abscesses.
 Hematoma.
 Phylloides tumour
 Fibroadenoma.
Diffuse edema changes : A difficult type of carcinoma to distinguish is one that does 
not produce a mass but only diffuse changes in echotexture and parenchymal pattern.
• Subtle increased reflectivity of parenchyma and subcutaneous fat.
• Loss of normal orientation of tissue planes.
• Poor differentiation in the fat-parenchyma interface.
DD of diffuse edema :
 Lobular and ductal carcinoma, inflammatory carcinoma.
 Breast contusion.
 Congestive cardiac failure ( usually bilateral).
 Breast / chest wall irradiation.
 Superior vena cava obstruction.
 Axillary Lymphatic obstruction.
Calcifications : Breast carcinoma may produce calcification both with and without 
mass. Calcification of sufficient size and clustered variety in a homogenous tissue can be 
picked up by USG.
Intracystic carcinomas : Rare lesions, usually papillary carcinoma that has obstructed a 
duct and bleed producing a blood filled cyst.
DD of intracystic mass :
 Papillary carcinoma
 Necrotic solid tumor
 Cysts containing hemorrhage, debirs
 Abscess
 Hematoma
With tha aid of the above criteria USG can come to a reliable diagnosis of breast 
lumps,  depending upon the size  of  the  lesions.  The  minimum size  of  cystic  lesions 
picked up by USG are 2-3 mm. Solid lesions > 0.5 cm are usually categorized with 
accuracy, 80% of solid lesions >2 cms and, 20% of lumps> 1-2cms 5% of lumps <1cm 
is the diagnostic accuracy of USG.
***** 
INDICATIONS FOR BREAST ULTRASOUND
From the above discussion we can summarise the now standardized indications 
for Breast Ultrasound as follows :
1. Evaluation of a palpable lump or mammographic abnormality.
2. To confirm the existence of a lesion and its nature.
3. Single imaging modality in our patients or in pregnant or lactating patients 
who present with symptoms.
4. To differentiate solid from cystic lesions.
5. For pathological examination of indeterminate lesions-guided FNA/CNB can 
be carried out.
6. Pre operative localization of lesions with needle placements, documentation of 
lesion removal by Usg of biopsy specimen.
7. Follow up of surgically altered breast – by tracing it through the breast and 
subcutaneous layer to the biopsy scar on skin, as well as for guidance for FNA/
CNB.
8. Follow up after augmentation mammoplasty to detect extracapsular rupture / 
contour abnormalities of the prosthesis.
9. Follow up of probably benign lesions that have not been biopsied.
10. Adjunctive to mammography as a screening tool for Carcinoma breast.
*****
ADVANTAGES OF USG OVER BREST MAMMOGRAPHY
1. No risk of radiation and its inherent consequences.
2. Can quality a lesion-as size, shape, echogenicity and relation to surrounding 
tissues as against a mammographic report of a ‘density’ which is less specific.
3. Sonographically guided biopsies are more accurate than streotactic biopsies as 
the needle can be visualized in real time throughout the entire procedure. This 
adds confidence that the biopsy sample was obtained from the lesion.
4. Mammographic  positioning  for  pre-operative  localization  of  the  masses  is 
cumbersome  and  time  consuming  and  less  accurate.  Hence  USG  is  the 
modality of choice for guidance.
5. Surgically  altered  breast  has  confusing  findings  and  is  non-informative  on 
mammography.
6. Palpable  lumps  following  extracapsular  rupture  of  a  prosthesis  may  be 
impossible to image by mammography.
7. Long term follow-up of benign nodules not excised is associated with risk of 
radiation on mammography and hence best performed by USG.
***** 
LIMITATIONS OF BREAST ULTRASOUND
Breast ultrasound usage is avoided in certain situations where no efficacy has been 
documented:
1. Routine evaluation of post operative breast.
2. Cancer Screening – as USG cannot detect all the non-palpable cancers that are 
also missed on mammography.
3. Cannot detect microcalcification well; small solid lesions in fatty or mixed breast 
tissue are not sonographically visible.
4. High false negative rate for non palpable cancers, (23%) which are smaller, 
clinically occult.
5. Substantial false positive rate-sonogram may pick up ‘lesions’ which are rarely 
clinically significant.
6. Unreliable in lesions<1 cm.
7. Less accurate in dense breasts.
These data suggest that breast ultrasound can be useful both as a single imaging 
modality and as a adjunct of mammography in evaluation of patients with breast Jumps. 
In  addition,  ultrasound  facilitates  preoperative  needle  biopsy  of  non-palpable 
abnormalities, permitting timely and cost effective patient care.
*****
FINE NEEDLE ASPIRATION CYTOLOGY
The advent of cytology and availability of experienced cytologists has diminished 
the diagnostic role of excision biopsy especially with regard to breast lumps.
FNAC can play a significant role in the early diagnosis of breast lumps to rule out 
malignancy, as an attractive alternative to open biopsy. It is our responsibility to further 
the  integrity  of  this  important  procedure by  understanding the merits  and pitfalls  of 
breasts FNAC and adhering to the defined guidelines.
HISTORY :
Martin and Ellis in 1926, New York first introduced the concept of FNAC in the 
midst  of  controversies  regarding the credibility  of  the procedure.  Breast  FNAC is  a 
simple complex procedure that is influenced by many variables. Accurate interpretation 
of  breast  FNAC  requires  clear  guidelines  for  specimen  acquisition,  staining  and 
preparation.
Bamforth in 1966 defined cytology as;  “The examination of cells  obtained by 
needle  or  drill  biopsy  in  solid  organs  or  tissue  masses  or  form cut  surface  of  such 
materials freshly removed by surgical biopsy:.
Innumerable studies have now shown that cytological examination of cells obtained 
this way is a rapid and reliable method of diagnosing malignant diseases of the breast.
REQUIRMENTS :
1. Spirit swab to clean the skin.
2. Disposable 10ml or 20ml syringe with fine needle 22G/23G.
3. A number of 76mm x 26mm microscopic Slides.
4. Fixatives like cytofix solution which is a commercial preparation, containing 
absolute alcohol slides.
5. Transport box for prepared slides.
6. Complete lab. Request form giving patient’s particulats
PROCEDURE : 
The  Procedure  is  usually  performed  without  anaesthesia.  Very  rarely  local 
anaesthesia is used. Local anaesthesia is generally not necessary because it is painful and 
may obsure the mass.
1. The skin over the lump is wiped with antiseptic and the lump is fixed between 
the fingers and the thumb and held steadily for needling. Then needle is guided 
through the skin into the lesion.
2. Once the needle is felt to enter the lesion, the plunger is retracted to create 
vacuum. Should the lesion prove to be cystic the fluid should be aspirated in its 
entirety  and  expressed  into  a  universal  container  and  sent  for  cytological 
examination.
3. If the lump is found to be solid, the needle is gently moved back and forth into 
the substance of the tumor three or four times and is inserted into a different 
part of the tumor each time to dislodge the cells from the tumor, so that the 
aspirate will contain the sufficient material for cytological studies.
4. Throughout the technique a negative pressure must be sustained in the syringe. 
Only after the tumor has been repeatedly probed, should suction be released 
and the  pressure  in  the  syringe  allowed to  return gradually  to  atmospheric 
pressure  and the  needle  is  withdrawn from the breast.  The  pressure  in  the 
syringe must be adjusted in a way, so that the aspirated cells are retained in the 
lumen of the needle, sustained suction as the needle is withdrawn result in, the 
cells  being  withdrawn  into  the  barrel  of  the  syringe  rendering  them 
inaccessible for processing.
PREPARATION OF ASPIRATE :
It  is  possible  to  make  smear  directly  from  the  aspirate  in  the  outpatient 
department.  Alternatively,  the  aspirated  cells  can  be  suspended  in  fixative  and 
transferred to cytologic laboratory for processing.
PREPARATION OF SMEAR :
 After aspiration the needle and syringe are withdrawn from the skin.
 Although nothing is visible in the syringe cells should have collected inside the 
bore of the needle.
 The needle is disconnected from the barrel, the syringe is filled with air.
 A clean glass slide should be ready and the needle is reconnected to the barrel and 
the aspirated material is blown out into the slide.
 Any large tissue fragments which do not spread easily should be crushed between 
the cover slip and the slide.
 The  smear  is  air  dried  and  fixed  in  cytofix  solution.  Then  the  slide  is  duly 
labelled.
FINATIVES :
A number of fixatives are used in cytology –
• 95% Ethyl alcohol
• 95% Ethyl Alcohol with 3% glacial acetic acid – to improve the nucleoprotein 
fixing properties.
STAINING PROCEDURES :
Some cytopathologists prefer to interpret these slides stained
 Papanicolaou method – when available this may be preferred in cytology for its 
superior  display of nuclear  morphology and clear translucent  demonstration of 
cytoplasm.
 Hematoxylin and Eosin method.
*****
NORMAL CYTOLOGY OF THE BREAST
The  mammary  gland  is  a  compound  gland  made  up  of  independent  units 
containing their own ducto-alveolar systems.
The alveoli are lined by simple cuboidal or low cuboidal epithelium which may 
alter in size depending on the secretary status of the breast. The ducts are also similar in 
lining,  becoming  pseudostratified  along  the  main  lactiferous  and  stratified  as  they 
approach the nipple.
The typical cytological features in different breast condition are given below.
BENIGN :
FYBROADENOMA :
 Duct cells are seen in large group and sheets surrounded by “stripped” nucleus.
 A small degree of nuclear pleomorphism of duct cells is usually present.
 Their  high  cellularity  and  moderate  pleomorphism  can  be  mistaken  for  a 
malignancy.
FIBROCYSTIC DISEASE :
 Numerous small foam  cells and large metaplastic apocrine cells with acidophilic 
cytoplasm.
 Dark pyknotic nuclei,
Sheets and clusters of uniform elongated cell; with transparent cytoplasm and having 
dendrite process.
PLASMA CELL MASTITIS :
 Foam cells and sheets of depenerate epithelial cells are common.
 Lipid containing macrophages and occasional foreign body giant cells.
 Diagnostic feature is presence of large amounts of plasmacytes, Lymphyocytes 
and esinophils and few neutrophils.
MALIGNANCY :
There are structured criteria for the diagnosis of malignancy by cytology, which 
are stratified into :
 Structural alterations in the cells.
 Changes in inter relationship of cells in cell clusters.
 Indirect criteria.
Structural modifications :
 Alterations  of  nuclear  cytoplasmic  ratio  with  disproportionate  enlargement  of 
nuclei.
 Hyperchromasia  due  to  increased  chromosomal  content,  aberrant  chromatin 
pattern.
 Increased number of nucleoli beyond the normal.
 Multinucleation  with nuclear atypia, abnormal mitotic figures.
 Marked thickening of nuclear membrane.
 Cytoplasmic  changes  enhanced  by  staining,  such  as  pronounced 
basophilia/acidophilia.
 Presence of cytoplasmic inclusions like pigment granules, leukocytes and cellular 
debris.
 Atypical vacuolation especially in adenorcarcinoma.
Cell –Cell changes :
 Enlargement of cells beyond normal shape.
 Aberrant forms with associated nuclear atypia.
 Degenerative or necrotic changes.
 Lack of uniform orientation of cells and nuclei.
 Anisocytosis/anisokaryosis  –  with  marked  variation  in  size  of  cells/nuclei 
within the same cell cluster.
 Loss of distinct cell boundaries.
 Dense grouping of and crowding of cells and nuclei.
 Engulfment of one cell by another.
 Cells grouping into characteristic patterns.
Indirect Changes :
 Presence of blood.
 Increased Lymphocytes.
 Prominent histiocytes and polymorphonuclear cells.
*****
ADVANTAGES OF FNAC :
1. Does not require anaesthesia.
2. Tolerated by patients as an OP procedure.
3. No secialized equipment required.
4. No damage to breast tissue that may occur with open biopsy.
5. Though small hematomas may be encountered, neither hemorrhage nor sepsis is 
noted.
6. Remote chances of tumor seeding along needle tract.
7. Lymphatic / vascular dissemination of tumor is virtually unknown.
8. Can easily diagnose cysts / abscesses and treat them.
9. Eliminated need for open biopsy when a diagnosis of carcinoma is made that is 
the incidence of false positive in malignancy is almost nil.
10. Can be easily repeated.
LIMITATIONS
1. Cannot qualify the type of malignancy.
2. False negative reporting when
a. Small tumors <1 cm.
b. Sclerotic lesions.
c. Deep seated tumors.
d. Large/pendulous breasts.
e. Lesions beyond the length of the needle.
*****
CORE NEEDLE BIOPSY (CNB)
Dominant lumps >2 cm in diameter can be approached by a wide bore cutting 
needle; such as Tru-Cut needle that the advantage of producing a core of tissue which 
can be paraffin embedded and used as a normal histological speciman with a modern 
spring loaded device, with a local amaesthesia to the skin; a series of high quality cores 
can be obtained rapidly and almost painlessly.
ADVANTAGES :
 Ability to obtain a core of tissue that is sufficiently large for HPE
 Providing more details of tumor structure.
 Ability to distinguish between invasive and IDCA.
 Any pathologist can interpret the results obviating the need for special skill of a 
cytopathologist.
 Large amount of prognostic information can be obtained including.
• Biological grade
• Receptor level
• DNA analysis
DISADVANTAGES :
Risk of seeding the needle tract with tumor cells.
Biopsy should be adjusted to avoid carrying potentially malignant tissue into the chest 
wall.
False positive incase of radial scars.
False positive incase of hard lesions, deflecting the needle into surrounding fat.
Thus CNB can be adopted as an alternative office biopsy technique to FNAC 
carrying sensitivity of 89%-100%.
*****
AIM OF STUDY
The  study  is  conducted  with  the  objective  of  assessing  the  combined  and 
individual reliablility of the Modified Triple Test in making a pre-procedural diagnosis 
of palpable breast lumps.
The components of the Modified Triple Test are :
1. Clinical Examination (C/E)
2. Breast Ultrasonogram (USG)
3. Fine Needle Aspiration Cytology/Core Needle Biopsy
(FNAC/CNB)
*****
MATERIALS AND METHODS
A  prospective  cross  sectional  study  of  100  female  patients  attending  the  out 
patient department at the Department of General Surgery, Government Rajaji Hospital, 
Madurai, with the complaint of a palpable lump/lumps in the breast was undertaken.
Male  patients  and  female  patients  with  advanced  Breast  Cancer  that  makes 
diagnosis obvious were excluded from the study (n=32).
The inclusion criteria were :
1. Female >30 years.
2. C/o breast lump – clinically palpable as a localized lesion differing from the 
surrounding breast tissue.
Each patient was put through the Modified Triple Test. On the basis of a systematic 
clinical examination, the lumps were grouped as – Malignant, Benign or inconclusive.
The  lesions  were  classified  as  Malignant,  Benign  or  lnconclusive  based  on  the 
following features.
a. Malignant – ill defined, heterogenous mass with sharp angulations; presence of 
microcalcifications.
b. Benign lesions were either cystic or solid
Cysts – Round, oval, anechoic, well defined with through and through transmission in 
simple cysts. Abscesses show low level internal echoes.
Solid : 1. Fibroadenoma - Round, oval
 Bi/Trilobulated
 Well defined with pseudocapsule
 Homogenous internal echos
2. Fibroadenosis - Generalized increase in the fibroglandular
 elements of breast.
Hyperechoeic shadows with cystic areas
 No distortion of breast architecture
Ultrasound  examination  also  included  the  contralateral  breast,  axillae,  internal 
mammary  lymph  nodes.  For  deeply  seated  lesions  Sono-guidance  was  utilized  to 
aspirate cysts and to take biopsies.
After this, FNAC/CNB was  performed  by  the  attending  surgeon  and  sent  for 
cytological/Histopathological examination.
CHART – 3
FLOW CHART DEPICTING THE STUDY PROTOCOL
SAMPLE SIZE
N=100
INCLUDED IN STUDY EXCLUDED FROM
N=68 STUDY
N=32
  
MODIFIED TRIPLE TEST
       C/E CE MALIGNANT - 29
      USG USG BENIGN - 24
FNAC/CNB        FNA/CNB INCONCLUSIVE – 4
OBSERVATION EXCISION BIOPSY /
N=16 (22%) DEFINITIVE SURGERY
N=57
MALIGNANT    BENIGN
      N=24                  N=33
  SURGERY SURGERY / FOLLOW UP
FNAC was reported as follows :
a. Insufficient material Cell content in the aspirate too poor for
cytological assessment.
b. Benign cells : Sufficient material with benign cells
indicating Fibroadenoma of Fibrocstic
disease.
c. Atypical cells : Slight atypia; interpreted as benign lesion.
d. Suspicious : Malignancy – suspect cells; not interpretable
NO.OF PALPABLE
BREASI LUMPS
N=73
as carcinoma with certainity.
e. Carcinoma : Cells indicative of malignancy.
Results were interpreted as follows :
a-repeat FNAC/CNB
b,c-benign
d-inconclusive
c-malignant
The results of the modified Triple Test were then analysed individually and as a 
combination. Any component indicating a malignant report were taken as malignancy. 
Inconclusive reports were subject to excision biopsy on an inpatient basis. Patients with 
malignancy were treated with definitive surgery. The post procedural histopathological 
reports were compared to the results of the Modified Triple Test.
*****
DATA ANALYSIS
Of the patients randomly referred for the study (n=100), patients not fitting the 
inclusion criteria  were excluded (n=32).  Thus 68 patients  with 73breast  lumps were 
inducted into the study.
The MTT obviated excision biopsy in 16 patients (22%) and this is the potential 
advantage of this test. Thus the final study group (n=57) underwent the MTT followed 
by excision biopsy, the results of which were available for comparison.
The average age of women in this study was 41.84+9.1 The mean shifting to 47 
years in patients with malignancy, the youngest patient was 30 years and the oldest was 
65  years.  This  conforms  with  the  suitable  age  for  subjecting  patients  to  screening 
procedure  followed  worldwide  (i.e.)  above  40  years.  9  women  were  nulliparous  of 
which only 3 had malignant lesions. The rest (n-48) were nulliparous. The results do not 
point to any positive association between partiy and malignancy (P>0.05). (Table :1)
TABLE : 1
ASSOCIATION BETWEEN PARITY AND BREAST PATHOLOTY
Parity Malignant Benign
Nulliparous 3 6
Multipara 21 27
P>0.05
Benign lesions were more common amongst premenopausal women (n=33); 
though malignancy could not be excluded in this group (n=24). However, all the 
lesions detected in pecumenopausal (n=5) posmenopausal women were malignant. 
(N=6) (Table – 2)
TABLE : 2
ASSOCIATION BETWEEN MANSTRUAL STATUS AND MALIGNANCY
Menstrual status Malignant Benign
Postmenopausal 6 0
Perimenopausal 5 0
Premenopausal 13 33
P<0.001
On excision biopsy, the 57 lumps were confirmed histopathologically as cither 
Malignant (n=24) and Benign (n=33).
The pathological reports were :
Total of malignancies = 24
Intra Ductal Carcinoma = 20
Lobular Carcinoma = 1
Medullary Carcinoma = 1
Carcino Sarcoma = 1
Malignant cystosarcoma
Phylloides = 1
Total no. of Benign lesions = 33
Fibroadenoma = 14
Fibrocystic Disease = 10
Breast Abscess = 6
Benign cystosarcoma
Phylloides = 3
The associations between each component of MTT and the combined MTT with 
the biopsy report were subjected to computer generated analysis.
Clinical  examination  finding  of  a  hard,  irregular  lump  was  more  like  to  be 
malignant,  while a  soft  or  firm mass with regular  surface suggested benign  lesions 
(P>0.001).  Benign  lesions  most  often  confused  with  malignancy  were  Benign 
cystosarcoma phylloides & Fibrocystic disease. (Table-3)
Table : 3
Consistency Malignancy Benign
Hard 18 3
Firm 5 30
Soft 0 1
Surface
Irregular 18 6
Regular 6 27
P<0.001
The intial indications of USG in differentiating a solid from cystic lesions may be non 
benefical in coming to a correct diagnosis. Our study shows no association between 
character of the lesion and diagnosis (P>0.05)
(Table – 4)
TABLE :4
ULTRASOUND FINDINGS AND HPE
Malignant Benign
Cystic 2 6
Solid 22 28
A regular, well defined; hyperechoeic lesion was usually benign. An irregular; ill 
defined mixed echogenic  mass  indicated  malignancy.  Hypoechoeic  lesions  were  not 
characteristic  of  either  (P=0.05).  Echogenicity  could  not  thus  be  used  as  a  singular 
feature to rule out malignancy except when they were hyperechoeic. (Table – 5)
TABLE –5
ECHOGENICITY OF LESIONS AND HPE:
Echogenicity Malignant Benign
Mixed 10 6
Hypoechoeic 14 23
Hyperchoeic 0 4
P = 0.05
Ultrasound detected Axillary nodes in all patients (n=12) found to be clinically 
node  positive;  however  it  could  not  distinguish  whether  the  node  had  malignant 
infiltration or not.
Ultrasound guided FNA/CNB was done in 6 cases; 2 of which were cystic lesions 
with a residual mass on aspiration of the cysts. Both turned out to malignancies missed 
on routine FNAC.
Amongst  the  individual  tests;  clinical  examination  was  more  likely  to  miss  a 
malignancy (Sensitivity 75%); as against ultrasound (Sensitivity 92%) or FNA / CNB 
(Sensitivity 100%). FNA/CNB correctly identified malignancy in all  24 cases;  while 
ultrasound  misinterpreted  1  case  as  malignant  (a  case  of  Benign  cystosarcoma 
phylloides) with specificities of 100% and 85% respectively.
The  MTT  was  85%  specific  with  malignant  lesions.  But  5  cases  were 
misdiagnosed as malignancies and turned out in 3 cases to be Fibrocystic Disease and 2 
cases were Benign cystosarcoma phylloides – both benign lesions. Inconclusive results 
(n=4) on MTT were also confirmed to be benign lesions. Thus MTT, though had false 
positives with respect to malignancy but no false negatives (i.e.,) a negative predictive 
value of 100%. These data are comparable to the original triple test with its sensitivity 
(65%-96%) and specificity (55%-98%) as reported in various studies (Tables – 6-10).
TABLE – 6
ASSOCIATION BETWEEN CLINICAL EXAMINATION AND
HISTOPATHOLOGY RESULT
CLINICAL 
EXAMINATION
HISTOPATHOLOGY
Maignant Benign
Malignant 18 1
Benign 1 23
Inconclusive 5 9
  
TABLE – 7
18
1
5
1
23
9
0
5
10
15
20
25
C/E
Malignant Benign
HPE
ASSOCIATION BETWEEN ULTRASONOGRAM AND HPE
ULTRASONOGRAM
HPE
Maignant Benign
Malignant 22 3
Benign 1 28
Inconclusive 1 2
0
5
10
15
20
25
30
Malignant Benign
TABLE – 8
ASSOCIATION OF FNA/CNB WITH HPE
CLINICAL 
EXAMINATION
HISTOPATHOLOGY
Maignant Benign
Malignant 18 1
Benign 1 23
Inconclusive 5 9
0
27
0
5
10
15
20
25
30
FNA/CNB
Malignant
HPE
East
West
North
TABLE – 9
ASSOCIATION MODIFIED TRIPLE TESTS WITH HPE
MTT HPE
Maignant Benign
Malignant 24 5
Benign 0 24
Inconclusive 0 4
24
0 0
5
24
4
0
5
10
15
20
25
MTT
Malignant
HPE
TABLE – 10
STATISTICAL ANALYSIS OF THE STUDY
C/E USG FNA/CNB MTT
Sensitivity 75%
(53-80%)
92%
(72-99%)
100%
(83-100%)
100%
(83-100%)
Specificity 97%
(82-100%)
85%
(67-94%)
100%
(87-100%)
85%
(67-94%)
Positive
Predictive Value
95%
(70-99%)
81%
(61-93%)
100%
(83-100%)
83%
(64-93%)
Negative
Predictive Value
84%
(64-90%)
93%
(76-99%)
100%
(87-100%)
100%
(85-100%)
‘P’ Value <0.001 <0.001 <0.001 <0.001
FNA / CNB as a single test was a superior diagnostic test than the other two tests, 
but  only  when  complemented  by  them  could  the  lesion  be  characterized  in  all 
dimensions for the chosen interventional procedure.
When an  inconclusive  was  reported  the  likelihood of  malignancy increases  in 
ascending order from FNA/CN, USG to C/E (n=o, n=1, n=5) respectively. All 4 cases 
deemed inconclusive after MTT were later diagnosed as Fibrocystic disease.
CONCLUSION
Detection and management of a breast mass requires an optimal environment for 
interpretation,  relevant  use  of  clinical  information,  technically  excellent  imaging 
procedures, proper interpretation of finding and patient recommendations.
Our results show that the diagnostic accuracy of combined physical examination 
breast USG and FNA/CNB is comparable to that of histological examination.
A  fine  collaboration  between  experienced  radiologists,  cytologist  and  the 
Clinician is required.
Ultrasound when replacing mammography serve as effective an imaging modality 
in palpable breast lumps and is more comprehensive.
Ultrasound breast aids biopsy techniques by guidance to the representative area 
than increasing yield.
CNB is a suitable alternative when FNA is inconclusive and may offer additional 
information.
Thus the use of MTT to complement findings in differential diagnosis of a lesion 
in  a  symptomatic  women  seeking  medical  care  deserves  acceptance  and  further 
evalution. This may lead to less delay in treatment when malignancy is suspected and to 
avoidance of surgical exploration when a benign nature of lesion is suspected.

